Form 4: Prestige Consumer Healthcare Executive Acquires Restricted Stock Units

Adel Mekhail, EVP of Marketing & Sales at Prestige Consumer Healthcare, reports acquisition of restricted stock units.

Summary

• Adel Mekhail, an executive at Prestige Consumer Healthcare Inc., filed a Form 4.
• The form details a transaction on May 5, 2025, where Mekhail acquired 2,622 shares of common stock.
• These shares were acquired as restricted stock units (RSUs) at a price of $0.
• Following the transaction, Mekhail directly owns 21,365 shares of Prestige Consumer Healthcare Inc.
• The restricted stock units vest in three equal installments of 874 shares each on May 5, 2026, 2027 and 2028.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing related to executive compensation. The acquisition of stock can be seen as a slightly positive sign, but it's not a major event.

Positives

• The acquisition of restricted stock units by an executive can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The vesting schedule of the restricted stock units indicates a long-term incentive for the executive to contribute to the company's success over the next three years.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing is typical for executives receiving stock-based compensation.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns executive interests with company performance.

Key Dates

Keywords

Prestige Consumer Healthcare, Form 4, Insider Trading, Stock Options, Restricted Stock Units, PBH, Mekhail, Executive Compensation